NCT05561478|Unknown
Comparison of Visual Outcomes After Implantation of the Synthesis Plus and Synthesis Plus Toric
DETPLUST
Loading search results
DETPLUST
Sponsor study identifier
observational
72
1 country
1
Study Start
October 10, 2022
Actual (reported)Primary Completion
August 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Prospective controlled monocentric study to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS IOL.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 27, 2022
Actual (reported)September 30, 2022
Actual (reported)October 10, 2022
Actual (reported)August 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
DCIVA at 66 cm
The primary objective of this study is to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS
1 month
Monocular UDVA
1 month
Monocular BCDVA
1 month
Monocular UIVA
1 month
Monocular DCIVA
1 month
Refraction
1 month
Requiring bilateral cataract surgery with pre-existing astigmatism
Requiring bilateral cataract surgery
Synthesis Plus IOLs are indicated for primary implantation for the visual correction of aphakia in adult patients.
Synthesis Plus Toric IOLs are indicated for primary implantation for the visual correction of aphakia in adult patients with pre-existing astigmatism.
Patient requiring bilateral cataract surgery
VISIS
Perpignan, 66000, France
Boris Dethinne, MD
Visis
First Submitted
September 27, 2022
First Posted
September 30, 2022
Study Start
October 10, 2022
Actual (reported)Primary Completion
August 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Patient Preference and Visual Quality With Contralateral Synergy Versus Panoptix
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
October 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 11, 2025
Record last verified: 2024-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: